A splice variant of GNB3 and peripheral polyneuropathy in type 1 diabetes

Disease Markers

Volumn 26, Issue 3, 2009, Pages 111-117

  Chistiakov, Dimitry A ^a   Spitsina, Ekaterina V ^a   Nikitin, Alexey G ^a   Strokov, Igor A ^b   Nosikov, Valery V ^a  

^a STATE RESEARCH INSTITUTE OF GENETICS AND SELECTION OF INDUSTRIAL MICROORGANISMS   (Russian Federation)

^b Russian Academy for Advanced Medical Studies Moscow   (Russian Federation)

Author keywords

C825T polymorphism; GNB3; Peripheral polyneuropathy; Susceptibility; Type 1 diabetes

Indexed keywords

GENOMIC DNA; GLUTATHIONE; GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN GNB3; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DIABETIC NEUROPATHY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SYSTOLIC BLOOD PRESSURE;

EID: 68649121153     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2009/426074     Document Type: Article

References (30)

1. L. Birnbaumer, Expansion of signal transduction by G proteins. The second 15 years or so: from 3 to 16 alpha subunits plus betagamma dimmers, Biochim Biophys Acta 1768 (2007), 772-793.
2. D. Rosskopf, S. Busch, I. Manthey and W. Siffert, G protein beta 3 gene: structure, promoter, and additional polymorphisms, Hypertension 36 (2000), 33-41.
3. D. Rosskopf, K. Koch, C. Habich, J. Geerdes, A. Ludwig, S. Wilhelms, K.H. Jakobs and W. Siffert, Interaction of Gbeta3s, a splice variant of the G-protein Gbeta3, with Ggamma- and Galpha-proteins, Cell Signal 15 (2003), 479-488.
4. M. Lindemann, S. Virchow, F. Ramann, V. Barsegian, E. Kreuzfelder, W. Siffert, N. Müller and H. Grosse-Wilde, The G protein beta3 subunit 825T allele is a genetic marker for enhanced T cell response, FEBS Lett 495 (2001), 82-86.
5. H. Ristic, S. Srinivasan, K.E. Hall, A.A. Sima and J.W. Wiley, Serum from diabetic BB/W rats enhances calcium currents in primary sensory neurons, J Neurophysiol 80 (1998), 1236-1244.
6. K.E. Hall, J. Liu, A.A. Sima and J.W. Wiley, Impaired inhibitory G-protein function contributes to increased calcium currents in rats with diabetic neuropathy, J Neurophysiol 86 (2001), 760-770.
7. L. Shutov, I. Kruglikov, O. Gryshchenko, E. Khomula, V. Viatchenko-Karpinski, P. Belan and N. Voitenko The effect of nimodipine on calcium homeostasis and pain sensitivity in diabetic rats, Cell Mol Neurobiol 26 (2006), 1541-1557.
8. 2+ channels as integrators of G protein-mediated signaling in neurons, Mol Pharmacol 66 (2004), 1071-1076.
9. G.J. Biessels, M.P. ter Laak, F.P. Hamers and W.H. Gispen, Neuronal Ca2+ disregulation in diabetes mellitus, Eur J Pharmacol 447 (2002), 201-209.
10. C.A. Stockmeier, Neurobiology of serotonin in depression and suicide, Ann NY Acad Sci 836 (1997), 220-232.
11. L.A. Catapano and H.K. Manij, G protein-coupled receptors in major psychiatric disorders, Biochim Biophys Acta 1768 (2007), 976-993.
12. W. Siffert, G protein beta 3 subunit 825T allele, hypertension, obesity, and diabetic nephropathy, Nephrol Dial Transplant 15 (2000), 1298-1306.
13. W. Siffert, G protein polymorphisms in hypertension, atherosclerosis, and diabetes, Annu Rev Med 56(2005), 17-28.
14. A.G. Nikitin, D.A. Chudakova, I.A. Strokov, T.R. Bursa, D.A. Chistiakov and V.V. Nosikov, Leu54Phe and Val762Ala polymorphisms in the poly(ADP-ribose)polymerase-1 gene are associated with diabetic polyneuropathy in Russian type 1 diabetic patients, Diabetes Res Clin Pract 79 (2008), 446-452.
15. E. Bentler, O. Duron and B.M. Kelly, Improved method for the determination of blood glutathione, J Lab Clin Med 61 (1963), 882-888.
16. W. Siffert, D. Rosskopf, G. Siffert, S. Busch, A. Moritz, R. Erbel, A.M. Sharma, E. Ritz, H.E. Wichmann, K.H. Jakobs and B. Horsthemke, Association of a human G-protein beta3 subunit variant with hypertension, Nat Genet 18 (1998), 45-48.
17. S. Purcell, S.S. Cherny and P.C. Sham, Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits, Bioinformatics 19 (2003), 149-150.
18. I.G. Obrosova, Update on the pathogenesis of diabetic neuropathy, Curr Diab Rep 3 (2003), 439-445.
19. J. Lee, S. Lee, S. Shin and H.S. Kang, Association between the GNB3 polymorphism and blood pressure in young Korean men, Med Sci Sports Exerc 37 (2005), 1138-1143.
20. P.G. Bagos, A.L. Elefsinioti, G.K. Nikolopoulos and S.J. Hamodrakas, The GNB3 C825T polymorphism and essential hypertension: a meta-analysis of 34 studies including 14,094 cases and 17,760 controls, J Hypertens 25 (2007), 487-500.
21. M.J. van Rijn, A.F. Schut, Y.S. Aulchenko, J. Deinum, F.A. Saved-Tabatabaei, M. Yazdanpanah M, A. Isaacs, T.I. Axen-ovich, I.V. Zorkoltseva, M.C. Zillikens, H.A. Pols, J.C. Witte-man, B.A. Oostra and C.M. Duijn, Heritability of blood pressure traits and the genetic contribution to blood pressure variance explained by four blood-pressure-related genes, J Hypertens 25 (2007), 565-570.
22. S. Hashim, Y. Li, A. Nakagura, S. Takeo and M.B. Anand-Srivastava, Modulation of G-protein expression and adenylyl cyclase signaling by high glucose in vascular smooth muscle, Cardiovasc Res 63 (2004), 709-718.
23. S. Hashim, Y. Li and M.B. Anand-Srivastava, G protein-linked cell signaling and cardiovascular functions in dia-betes/hyperglycemia, Cell Biochem Biophys 44 (2006), 51-64.
24. T. Inoguchi, T. Sonta, H. Tsubouchi, T. Etoh, M. Kakimoto, N. Sonoda, N. Sato, N. Sekiguchi, K. Kobayashi, H. Sumi-moto, H. Utsumi and H. Hawata, Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase, J Am Soc Nephrol 14(Suppl 3) (2003), S227-S232.
25. D.N. Martín, E.P. Anderu, R. Ramírez Lorca, P.S. García-Junco, I. Vallejo Maroto, R.A. Santos, M.L. Miranda Guisado, O.M. Grijavo, J.V. Ortiz and J. Carneado de la Fuente, G-protein beta-3 subunit gene C825 T polymorphism: influence on plasma sodium and potassium concentrations in essential hypertensive patients, Life Sci 77 (2005), 2879-2886.
26. K.A. Kles and A.I. Vinik, Pathophysiology and treatment of diabetic peripheral neuropathy: the case for diabetic neurovas-cular function as an essential component, Curr Diabetes Rev 2 (2006), 131-145.
27. C. Figueroa-Romero, M. Sadidi and E.L. Feldman, Mechanisms of disease: the oxidative stress theory of diabetic neuropathy, Rev Endocr Metab Disord 9 (2008), 301-314.
28. M. Anjaneyulu1, A. Berent-Spillson and J.W. Russell, Metabotropic glutamate receptors (mGluRs) and diabetic neuropathy, Curr Drug Targets 9 (2008), 85-93.
29. N.S. Shcherbak and E.I. Schwartz, The C825T polymorphism in the G-protein beta3 subunit gene and diabetic complications in IDDM patients, J Hum Genet 46 (2001), 188-191.
30. T. Hayakawa, T.Takamura, T.Abe andS. Kaneko, Association of the C825T polymorphism of the G-protein beta3 subunit gene with hypertension, obesity, hyperlipidemia, insulin resistance, diabetes, diabetic complications, and diabetic therapies among Japanese, Metabolism 56 (2007), 44-48.